dromlakhani Avoid statin use in pregnancy or when trying to become pregnant
STEP 1 — Gather Information
Assess pregnancy status, intention to conceive, last menstrual period, and contraceptive use in females of childbearing potential presenting for lipid therapy.
STEP 2 — Rule In / Rule Out
Is the patient pregnant or actively trying to become pregnant? If yes, proceed to Step 4 (avoid statin); if no, proceed to Step 3.
STEP 3 — Classify or Stratify
Evaluate lipid-lowering indication per guideline (e.g., LDL‑C >70 mg/dL, ASCVD risk, risk‑enhancing factors) to determine if statin therapy is otherwise indicated.
STEP 4 — Decide
If pregnant or trying to conceive, do not initiate statin; emphasize lifestyle modification and postpone pharmacologic lipid therapy until after pregnancy. If not pregnant and statin is indicated, initiate appropriate statin therapy.
Clinical Guardrails / Mimics / Pitfalls
Do not rely on statins for lipid control in pregnancy due to teratogenic risk (FDA Category X); avoid in lactation unless benefit outweighs risk; do not mistake elevated lipids in pregnancy as requiring statin therapy.
Concrete Clinical Example
A 32‑year‑old woman with PCOS and LDL‑C 160 mg/dL who is planning pregnancy; statin is withheld, lifestyle changes (diet, exercise) are started, and lipid therapy is reconsidered postpartum.
Source: Lipid Management in Patients with Endocrine Disorders: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2020, doi:10.1210/clinem/dgaa674